Tag: HER2

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to HER2

Top 5 Companies in the Breast Cancer Market: Emerging Trends and Key Market Insights

Added to Collection on: 2024-11-28 21:21:49

Tags for this article:

Breast cancer
HER2
Roche
Mammography
Genentech
Cancer
Triple-negative breast cancer
Oncology
Pfizer
Novartis
AstraZeneca
Breast cancer classification
United States

Click the tags to see associated articles and topics

View Article Details
OS Therapies Partners with B2i Digital to Engage with Biotech Investors Online

Added to Collection on: 2024-12-26 19:06:40

Tags for this article:

Antineoplastic drugs
Breast cancer
Immunology
Antibody-drug conjugate
Biotechnology
HER2
Osteosarcoma
OS Therapies Inc.
B2i Digital Inc.
OS Therapies Partners
OST

Click the tags to see associated articles and topics

View Article Details
OS Therapies Partners With B2i Digital to Engage With Biotech Investors Online

Added to Collection on: 2024-12-26 17:23:09

Tags for this article:

Immunology
Breast cancer
Antineoplastic drugs
Cancer treatments
Antibody-drug conjugate
Biotechnology
HER2
Forward-looking statement
Osteosarcoma
Antibody
OS THERAPIES
Digital, Inc.

Click the tags to see associated articles and topics

View Article Details
OS Therapies to Attend the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace

Added to Collection on: 2025-01-02 17:46:13

Tags for this article:

Breast cancer
Antineoplastic drugs
Immunology
HER2
Osteosarcoma
Priority review
Antibody-drug conjugate
OS Therapies Inc.

Click the tags to see associated articles and topics

View Article Details
Study Shows Real-World Outcomes of First-Line Palbociclib Plus Fulvestrant in HR+, HER2

Added to Collection on: 2025-01-19 03:05:37

Tags for this article:

Cyclopentanes
Lactams
Selective estrogen receptor degraders
Protein kinase inhibitors
Antiestrogens
Palbociclib
Fulvestrant
Breast cancer
HER2
CDK inhibitor
Dalpiciclib
Pfizer
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
AZ, Daiichi get FDA nod for Dato-DXd in breast cancer | pharmaphorum

Added to Collection on: 2025-01-19 02:36:53

Tags for this article:

Antineoplastic drugs
Orphan drugs
Immunology
Breast cancer
Lung cancer
Antibody-drug conjugate
Durvalumab
Trastuzumab deruxtecan
Non-small-cell lung cancer
HER2
Triple-negative breast cancer
Trastuzumab
AstraZeneca
Daiichi Sankyo

Click the tags to see associated articles and topics

View Article Details
EXUMA Biotech Announces Phase 1 Results for its Autologous HER2 Directed, Tumor ...

Added to Collection on: 2025-01-23 20:09:05

Tags for this article:

Breast cancer
Cancer treatments
HER2
Oncogenes
Tumor microenvironment
CAR T cell
Adoptive cell transfer
Trastuzumab
EXUMA Biotech Corp.

Click the tags to see associated articles and topics

View Article Details
Boost to Enhertu's prospects as FDA clears Roche diagnostic - pharmaphorum

Added to Collection on: 2025-02-02 21:10:02

Tags for this article:

Orphan drugs
Antibody-drug conjugates
Immunology
Antineoplastic drugs
Cancer treatments
Trastuzumab deruxtecan
HER2
Trastuzumab
Antibody-drug conjugate
Breast cancer
Pertuzumab
Dalpiciclib
Roche Diagnostics
Daiichi Sankyo

Click the tags to see associated articles and topics

View Article Details
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 ...

Added to Collection on: 2025-02-13 21:19:16

Tags for this article:

Breast cancer
Cancer treatments
Immunology
Chloroarenes
Neratinib
Nitriles
Trastuzumab
HER2
Puma Biotechnology
Trastuzumab emtansine
Xavier Pivot

Click the tags to see associated articles and topics

View Article Details
Puma Biotechnology Q4 2024 Earnings Call Scheduled for February 27 - Stock Titan

Added to Collection on: 2025-02-13 21:18:00

Tags for this article:

Chloroarenes
Cancer treatments
Neratinib
Nitriles
Quinolines
Puma Biotechnology
HER2
Puma
Trastuzumab
Alisertib
Breast cancer

Click the tags to see associated articles and topics

View Article Details